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Summary Statement: An artificial intelligence algorithm differentiated between COVID-19
pneumonia and non-COVID-19 pneumonia in chest x-ray radiographs with high sensitivity and
specificity.
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Key Results:
The overall performance of artificial intelligence (AI) algorithm achieved an area under

es

the curve of 0.92 on the test dataset of 5869 chest x-ray radiographs (CXRs) from 2193
patients (acquired from multiple hospitals and multiple vendors)


Over a set of 500 randomly selected test CXRs, the AI algorithm achieved an AUC of

Pr

0.94, compared to an AUC of 0.85 from three experienced thoracic radiologists.

Abbreviations:

AUC = area under the receiver operating characteristic curve, COVID-19 = coronavirus disease
2019, CXR = chest x-ray radiograph, ROC = receiver operating characteristic, RT-PCR =
reverse transcriptase polymerase chain reaction, SARS-CoV-2 = severe acute respiratory

In

syndrome coronavirus 2

Abstract
Background
Radiologists are proficient in differentiating between chest x-ray radiographs (CXRs) with and
without symptoms of pneumonia, but have found it more challenging to differentiate CXRs with
COVID-19 pneumonia symptoms from those without.

s

Purpose
To develop an artificial intelligence algorithm to differentiate COVID-19 pneumonia from other

Materials and Methods

es

causes of CXR abnormalities.

In this retrospective study, a deep neural network, CV19-Net, was trained, validated, and tested
on CXRs from patients with and without COVID-19 pneumonia. For the COVID-19 positive
CXRs, patients with reverse transcriptase polymerase chain reaction positive results for severe
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acute respiratory syndrome coronavirus 2 with positive pneumonia findings between February 1,
2020 and May 30, 2020 were included. For the non-COVID-19 CXRs, patients with pneumonia
who underwent CXR between October 1, 2019 and December 31, 2019 were included. Area
under the receiver operating characteristic curve (AUC), sensitivity, and specificity were
calculated to characterize diagnostic performance. To benchmark the performance of CV19-Net,
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a randomly sampled test dataset containing 500 CXRs from 500 patients was evaluated by both
the CV19-Net and three experienced thoracic radiologists.
Results

A total of 2060 patients (5806 CXRs; mean age 62 ± 16, 1059 men) with COVID-19 pneumonia
and 3148 patients (5300 CXRs; mean age 64 ± 18, 1578 men) with non-COVID-19 pneumonia
were included and split into training + validation and test datasets. For the test set, CV19-Net

achieved an AUC of 0.92 (95% confidence interval [CI]: 0.91, 0.93) corresponding to a
sensitivity of 88% (95% CI: 87%, 89%) and a specificity of 79% (95% CI: 77%, 80%) using a
high sensitivity operating threshold, or a sensitivity of 78% (95% CI: 77%, 79%) and a
specificity of 89% (95% CI: 88%, 90%) using a high specificity operating threshold. For the 500
sampled CXRs, CV19-Net achieved an AUC of 0.94 (95% CI: 0.93, 0.96) compared to a 0.85

s

AUC (95% CI: 0.81, 0.88) of radiologists.
Conclusion

es

CV19-Net was able to differentiate COVID-19 related pneumonia from other types of
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pneumonia with performance exceeding that of experienced thoracic radiologists.

Introduction
The outbreak of coronavirus disease 2019 (COVID-19) (1) began with the initial diagnosis of an
unknown viral pneumonia in late 2019 in Wuhan, China and subsequently spread around the
globe as a pandemic. Ribonucleic acid sequencing of respiratory samples identified a novel
coronavirus (called severe acute respiratory syndrome coronavirus 2 or SARS-CoV-2) as the
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underlying cause of COVID-19. Patients with COVID-19 present with symptoms that are similar
to other viral illnesses, including influenza, as well as other coronaviruses such as severe acute
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respiratory syndrome (2,3) and Middle East respiratory syndrome (4). Symptoms are nonspecific
and include fever, cough, fatigue, dyspnea, diarrhea, and even anosmia (5,6). The radiographic
signs are also nonspecific and can be observed in patients with other viral illnesses, drug
reactions, or aspiration (5,7,8).

The similarities in clinical presentation across other reactions and illnesses creates challenges
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towards establishing a clinical diagnosis. Currently, reverse transcriptase polymerase chain
reaction (RT-PCR) is the reference standard method to identify patients with COVID-19
infection (9). In addition to the RT-PCR test, CT has also been widely used in China, and
occasionally in other countries, to provide additional means in COVID-19 diagnosis and
treatment response monitoring process (5,10,11). However due to concerns of contamination of
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CT imaging facilities and exposure to health care workers, healthcare professional organizations
(12-14) do not recommend CT imaging as a general diagnostic imaging tool for patients with
COVID-19.

Rather, major medical societies recommend the use of chest x-ray radiography (CXR) as part of
the workup for persons under investigation for COVID-19 due to its unique advantages: almost
all clinics, emergency rooms, urgent care facilities, and hospitals are equipped with stationary

and mobile radiography units, including both urban and rural medical facilities. These units can
be easily protected from exposure or disinfected after use and can be directly used in a contained
clinical environment without moving patients. However, the major challenge with the use of
CXR in COVID-19 diagnosis is its low sensitivity and specificity in current radiological practice.
A recent study found that the sensitivity of CXRs was poor for COVID-19 diagnosis (11). To
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some extent, this poor diagnostic performance can be attributed to the fact that many radiologists
are seeing COVID-19 induced pneumonia cases for the very first time and radiologists need to
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read more cases to learn both the common and unique imaging features of this disease.

In this regard, machine learning, particularly deep learning (15,16) methods, have unique

advantages in quick and tireless learning to differentiate COVID-19 pneumonia from other types
of pneumonia using CXR images. The purpose of this study was to train and validate a deep
learning method to differentiate COVID-19 pneumonia from other causes of CXR abnormalities

Pr

and test its performance against thoracic radiologists.

Materials and Methods

This retrospective, Health Insurance Portability and Accountability Act -compliant study was
approved by the Institutional Review Board at both Henry Ford Health System, Detroit, MI and
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the University of Wisconsin-Madison, Madison, WI. Written informed consent was waived
because of the retrospective nature of the data collection and the use of de-identified images.
Patient Datasets

For algorithm development, we included CXRs from patients with and without COVID-

19 (COVID-19 positive and non-COVID-19) pneumonia from Henry Ford Health System, which
includes five hospitals and more than 30 clinics. The pneumonia findings for both COVID-19

and non-COVID-19 pneumonia were found using a commercial natural language processing tool
(InSight, Softek Illuminate) that searched radiologist reports for positive pneumonia findings.
Searches were performed over all radiologist reports at the institution over the COVID-19 and
non-COVID-19 timeframes. The patients with non-COVID-19 pneumonia were selected based
solely on positive pneumonia findings in the report and the date of study (October-December
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2019). The patients with pneumonia from the COVID-19 timeframe were cross-referenced with
the list of patients positive for COVID-19 to find the list of patients that had both positive
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pneumonia and positive COVID-19.

The inclusion criteria for the non-COVID-19 pneumonia were patients that underwent
frontal view CXR, had pneumonia diagnosis, and imaging was performed between October 1,
2019 and December 31, 2019 (before the first COVID-19 positive patient in the United States
was confirmed on January 19, 2020 in Seattle, WA [17]). Since these CXRs predate the first
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confirmed COVID-19 cases in the United States, we consider these CXRs to be positive for nonCOVID-19 pneumonia. Patients under the age of 18 were excluded.
The inclusion criteria for the COVID-19 positive group were patients that underwent

frontal view CXR, with RT-PCR positive test for SARS-CoV-2 with a diagnosis of pneumonia
between February 1, 2020 and May 31, 2020. Patients were excluded if CXR was performed

In

more than 5 days prior or 14 days after RT-PCR confirmation.

The resulting datasets consisted of 5805 CXRs with RT-PCR confirmed COVID-19

pneumonia from 2060 patients and 5300 CXRs with non-COVID-19 pneumonia from 3148
patients for use in this study (Figure 1 and 2).

CXR Acquisition
These CXRs were from six different vendors: Carestream Health (DRX-1, DRXRevolution), GE Healthcare (Optima-XR220, Geode Platform), Konica Minolta (CS-7), Agfa
(DXD40, DXD30, DX-G), Siemens Healthineers (Fluorospot Compact FD), and Kodak (Classic
CR).

s

Training, Validation, and Test Datasets
It is important to consider any variables from CXR acquisition (such as x-ray tube
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potential [kVp values] and x-ray exposure levels) to mitigate any biases in algorithm training (for
additional details see Appendix E1). Since our overarching objective was to develop a deep
learning algorithm that could be successfully applied broadly to CXRs taken at different

hospitals and clinics where CXR imaging systems from different vendors are used, our strategy
was to train the deep learning method using a dataset with images from different vendor systems.
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CXRs were randomly selected from the four major vendors (Carestream Health, GE Healthcare,
Konica Minolta, and Agfa) of the dataset and these vendors were randomly anonymized as V1,
V2, V3 and V4. The curated CXRs were first grouped by vendors and a total of 5236 CXRs
(2582 CXRs from the COVID-19 cohort and 2654 CXRs from the non-COVID-19 pneumonia
cohort) were used as training and validation to develop our deep learning algorithm, which is
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referred to as CV19-Net.

The remaining data were used for performance evaluation of the developed CV19-Net

algorithm, including 3223 positive COVID-19 CXRs from 1007 patients and 2646 non-COVID
pneumonia CXRs from 1186 patients. A patient-based data partition scheme was used to ensure
that CXRs of any particular patient will only appear in either the training dataset or test dataset,
but not both. See Table 1 for details of the data partition.

Image Preprocessing in Machine Learning
The Digital Imaging and Communications in Medicine files of the collected CXRs were
resized to 1024 x 1024 pixels and saved as 8-bit Portable Network Graphics grayscale images.
Before being fed into the CV19-Net, images were further downscaled to 224 x 224 pixel,
converted to red-green-blue images and normalized based on the mean and standard deviation of
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images in the ImageNet dataset (18). (See Appendix E2)
Neural Network Architecture and Training Strategy

es

The CV19-Net used in this work is an ensemble of 20 individually trained deep neural

networks. Each deep neural network consists of four modules of the well-known DenseNet (19)
architecture, with a binary classifier to differentiate COVID-19 pneumonia from other types of
pneumonia. A three-stage transfer learning approach was used to train the 20 individual deep
learning neural networks of the same architecture. After the CV19-Net was trained, an input
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CXR was fed into the CV19-Net to produce 20 individual probability scores, then a final score
was generated by performing a quadratic mean. This process is similar to the group diagnosis
protocol used in difficult clinical decision-making processes in that 20 individual “experts” are
asked to evaluate the same input image, and then a final group score is generated by a voting
scheme. This final probability score was then compared with a chosen decision-making threshold
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value to classify the input CXR images as COVID-19 or non-COVID-19 pneumonia (For details
of the network architecture and the training process, see Appendix E3. The code is available at
https://github.com/uw-ctgroup/CV19-Net).
Human Radiologists Reader Study to Generate Performance Reference
To benchmark the performance of the developed CV19-Net, three experienced thoracic
radiologists (JDN, TKS, and MLS with more than 9, 14 and 34 years of experience, respectively)

performed binary classification (COVID-19 positive or COVID-19 negative) reader study using
a randomly selected subset of the test images (Figure 1): 500 CXRs from 500 different patients
(250 COVID-19 pneumonia and 250 non-COVID-19 pneumonia). All three readers have recent
experience with COVID-19 CXR interpretation. The three readers were blinded to any clinical
information and read all exams independently between June 1, 2020 and June 15, 2020. The
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three readers dictated each CXR as either COVID-19 positive or COVID-19 negative pneumonia
using a picture archiving communication systems workstation under standard reading conditions.

es

To compare the performance between CV19-Net and the three readers on the same test data set,

the threshold of CV19-Net was adjusted to match the corresponding specificity of the radiologist
and then the diagnostic sensitivity was compared between each radiologist and CV19-Net.
Statistical Analysis

To evaluate the diagnostic performance of the trained CV19-Net, the area under the receiver-
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operating-characteristic curve (AUC), sensitivity, and specificity were calculated over the entire
test cohort of 5869 CXRs from 2193 patients. The 95% confidence intervals (CI) for the
performance metrics were calculated using the statistical software R (version 4.0.0) with the
pROC package (20). The CI for AUC was calculated using DeLong’s nonparametric method
(21); CIs for sensitivity and specificity were calculated using the bootstrap method (22) with
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2000 bootstrap replicates. The McNemar test was performed to compare the sensitivity of CV19Net to the three radiologists. P-value hypothesis testing method was used for each comparison
(For details see Appendix E5). P < .05 was considered to indicate a statistically significant
difference.

Results

Patient Overview
A total of 3507 (5672 CXRs) patients with non-COVID-19 pneumonia met the inclusion
criteria. There were 359 patients (372 CXRs) that were under 18 years of age that were excluded.
A total of 2086 patients (6650 CXRs) with COVID-19 pneumonia met the inclusion criteria and
340 patients (845 CXRs) were excluded for having CXRs performed outside of the preferred
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time window of RT-PCR (-5 to +14 days since positive test).
The resulting datasets that were used for the development (training + validation and

es

testing) consisted of 5805 CXRs with RT-PCR confirmed COVID-19 pneumonia from 2060

patients (mean age, 62 ± 16 years; 1059 men) and 5300 CXRs with non-COVID-19 pneumonia
from 3148 patients (mean age, 64 ± 18; 1578 men).

The data was randomized and partitioned based on data acquired on CXR equipment
from different vendors. A total of 2654 CXRs (1962 patients) with non-COVID-19 pneumonia
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and 2582 CXRs (1053 patients) with RT-PCR confirmed COVID-19 were used for training and
validation. A total of 2646 CXRs (1186 patients) with non-COVID-19 pneumonia and 3223
CXRs (1007 patients) with RT-PCR confirmed COVID-19 were used for CV19-Net testing,
resulting in 5869 CXR images from 2193 patients (mean age 63 ± 16 years, 1131 men) within
the test dataset (Figure 1).

In

Overall Performance of CV19-Net
The performance of the CV19-Net achieved an AUC of 0.92 (95% confidence interval

[CI]: 0.91, 0.93) for the overall test dataset. As shown in Figure 3A and Table 2, for a high
sensitivity operating threshold, this method showed a sensitivity of 88% (95% CI: 87%, 89%)
and a specificity of 79% (95% CI: 77%, 80%); for a high specificity operating threshold, it
showed a sensitivity of 78% (95% CI: 77%, 79%) and a specificity of 89% (95% CI: 88%, 90%).

The performance of CV19-Net for four major vendors and five major hospitals is presented in
Figure 3C.
The three radiologists’ interpretation results from the subset of 500 test images were
summarized by sensitivities of 42%, 68%, and 90%, respectively, and specificities of 96%, 85%,
and 55%, respectively. Using the interpretation results of the same image from three readers, an
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averaged receiver operating characteristic (ROC) curve with an AUC of 0.85 (95% CI: 0.81,
0.88) was generated for radiologists. As a comparison, when the CV19-Net was applied to the
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same sub-set of test images, it yielded an AUC of 0.94 and sensitivities of 71%, 87%, and 98%,
respectively, and specificities of 96%, 85%, and 55%, respectively, when choosing a matched
specificity to the performance of each radiologist (Figure 3B). All P-values were < .001,

indicating CV19-Net had better sensitivity than human radiologists at all matched specificity
levels. Figure 4 shows two example images in the reader study test dataset, which were correctly
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labeled by CV19-Net, but incorrectly labeled by all three radiologists. The heatmaps generated
by CV19-Net are also shown in Figure 4. See Appendix E4 for details on the heatmap
generation.

Performance by Age Group and Sex

The performance of CV19-Net is presented for patients with different age groups in
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Table 3 and for the two sexes in Table 4. There was no difference in CV19-Net performance
between sex (P = .17). However, results showed a difference in performance between wellseparated age groups (eg, age group of 18-30 years is different from age groups of 45-60 years
[P = .02], 60-75 years [P = .002], and 75-90 years [P < .001]) while no difference in neighboring
age groups (eg age groups 18-30 years compared to 30-45 years; P = .31) was found. See Table
E1 for details.

Performance vs Training Sample Size
The relationship between the achievable AUC of CV19-Net vs the needed training sample sizes
was systematically investigated to determine the training sample size used in this paper (See
Figure E5). The results demonstrated that more than 3000 training samples (1500 positive
COVID-19 cases and 1500 non-COVID-19) are needed to achieve an AUC better than 0.90.

increase of training samples.

es

Discussion

s

After the training sample size goes beyond 3000 the performance gain is diminished with the

It has been a routine clinical practice for radiologists to interpret chest x-ray radiographs with
and without symptoms of pneumonia. However, it has been much more challenging to

differentiate CXRs with COVID-19 pneumonia symptoms from those without due to the lack of
the training in reading in this pandemic. In this work, we have demonstrated that an artificial
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intelligence algorithm can be trained and used to differentiate coronavirus disease 2019

(COVID-19) related pneumonia from non-COVID-19 related pneumonia using CXR images,
with excellent performance on the same test image data set in terms of AUC of 0.94 (95% CI:
0.93, 0.96) compared to a 0.85 AUC (95% CI: 0.81, 0.88) of three thoracic radiologists.
Intensive efforts have been made globally through 2020 to seek fast and reliable machine
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learning solutions to help diagnose patients with COVID-19 and triage patients for proper
allocation of rather limited resources in combating this global pandemic (See Table E2 for a
summary of related studies). Most related studies used small datasets with fewer than 200
COVID-19 CXRs collected from various sources including cropped images from published
journals or from authors’ access to other image databases. Further, evaluations of these neural

networks were only performed over the same small data cohort. Due to the non-uniformity of
image quality in these small datasets, the apparent test performances were often biased (23).
In contrast, two recent studies (24,25) reported their results using relatively larger data
sets from clinical centers (one from Brazil with a total of 558 COVID-19 positive CXRs and the
other from the Netherlands with a total of 980 COVID-19 positive CXR images used in both
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training and testing). Schwab et al (24) trained a small number of conventional machine learning
algorithms from their dataset and reported an area under the curve (AUC) of 0.66 (95%
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confidence interval [CI]: 0.63, 0.70). In Murphy et al (25), a deep learning model was trained
using 512 COVID-19 positive CXRs combined with 482 COVID-19 negative CXRs and

reported a performance of AUC = 0.81 on CXRs from 454 patients. The potential variance of the
reported AUC performance values remains unclear since there was no 95% CI reported. Their
results were compared with that of six human radiologists, showing that the performance of their
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deep learning model is comparable with radiologists.

In our study, we systematically studied the performance of the trained deep learning

model and how it changes with an increase of the training dataset size (For details, see Figure
E5). With a training sample size of 1000 (500 positive and 500 negative cases), the achievable
AUC was found to be 0.86, similar to what was reported (0.81) in Murphy et al (25). The slightly
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higher performance of our network may be attributable to differences in data curation strategies,
as we included CXRs obtained contemporaneously with RT-PCR, within a narrow window (-5 to
+14 days).

This study has several limitations. First, we only considered the binary classification task:

COVID-19 pneumonia versus other types of pneumonia. Therefore, at this stage, the developed
algorithm should be used in adjunction to radiologist’s findings of pneumonia image features in

CXRs. For an automated artificial intelligence-assisted diagnostic system, it would be ideal to
have finer classification categories such as “Normal”, “Bacterial”, “Non-COVID-19 viral”, and
“COVID-19”. With global efforts in collecting CXRs with the above four labels, the work
presented here may be further enhanced in future work. Second, the data collection of data from
patients with COVID-19 pneumonia was conducted in the first peak of the COVID-19 pandemic.

s

As a result, the collected data may not reflect the true prevalence of the disease. We also
included multiple CXRs from the same patient since some patients took multiple exams as their
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diseases progress. One may question whether the use of multiple CXRs changes the performance
evaluation, to address this question, a single CXR image was randomly selected from multiple
CXRS per patient to participate in the overall test performance evaluation, and the overall AUC
did not change from 0.92. Third, although the method was tested over multiple hospitals and
clinics, the test sites need to be further expanded to determine whether the developed artificial
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intelligence algorithm in this work is generalizable to even broader population distributions over
different regions and continents. Finally, in radiologist reader studies, only the averaged receiver
operating characteristic (ROC) curve and the corresponding AUC was calculated based upon the
diagnosis of each CXR from three readers. Thus, the reported ROC curve and AUC are averaged
results from three independent readers. Ideally, each reader should have been asked to report
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their degree of confidence level in their diagnosis for each CXR and individual ROC and AUC
for each reader can then be calculated and reported.
In conclusion, the combination of chest radiography with the proposed CV19-Net deep

learning algorithm has the potential as an accurate method to improve the accuracy and
timeliness of the radiological interpretation of COVID-19 pneumonia.
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Figures

Figure 1: Study flowchart for data curation and data partition. Vendors 1-4 (V1-V4) are four
major vendors of the acquired chest x-ray radiographs (CXR) in the dataset. AI = artificial
intelligence, RT-PCR = reverse transcriptase polymerase chain reaction.

In

B

s

es

Pr

A

In

D

s

es

Pr

C

s
es
Pr

E

Figure 2: Detailed data characteristics. A, Age distribution of included patients. B, Distribution
of the delta (time between the positive reverse transcriptase polymerase chain reaction [RT-PCR]
test and the chest x-ray examination) for the positive cohort. A positive delta value indicates that
the chest x-ray examination was performed after the RT-PCR test. C, Distribution of the x-ray

In

radiograph vendors. D, Distribution of the use of computed radiography (CR) or digital
radiography (DX). E, Distribution of data from different hospitals (H01-H05 indicates the five
different hospitals and C01 to C30 indicate the 30 different clinics).
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Figure 3: Performance of CV19-Net. A, Receiver operating characteristic (ROC) curve of the total

Pr

test dataset (left) with 5869 CXRs and the probability score distribution (right), T1 and T2 denote
high sensitivity operating point and high specificity operating point, respectively. B, Pooled
performance of the three chest radiologists compared with CV19-Net for the 500 test cases. C,
ROC curves of CV19-Net for different vendors (V1-V4) and hospitals (H01-H05) in the test
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dataset.

B

s
Pr

es

A

In

Figure 4: Examples of CXRs and the network generated heatmaps from the reader study test set.

A, Left: a COVID-19 pneumonia case (64-year-old, male) that was classified correctly by CV19Net but incorrectly by all three radiologists. Right: the heatmap generated by CV19-Net overlaid
on the original image. The red coloring highlights the anatomical regions that contribute most to
the CV19-Net prediction. B, Left: a non-COVID-19 pneumonia case (58-year-old, female) which
was classified correctly by CV19-Net but incorrectly by all three radiologists. Right: the heatmap
highlights the anatomical regions that contribute most to the CV19-Net prediction.

Tables
Table 1. Training, Validation, and Test Datasets
Test
COVID-19
CXR
Patients
1757
743
715
424
527
106
159
80
65
56
3223
1007

Non-COVID-19
CXR
Patients
1042
417
556
289
373
300
375
280
300
269
2646
1186

s

V1
V2
V3
V4
VO
Total

Training and validation
Non-COVID-19
COVID-19
CXR
Patients
Patients
CXR
1399
1122
623
1497
458
332
269
457
544
308
108
400
181
200
53
300
NA
NA
NA
NA
2582
1962
1053
2654

es

Note.—Number of patients and CXRs in each dataset are shown. V1-V4 denotes Carestream Health, GE
Healthcare, Konica Minolta and Agfa, respectively. VO denotes Siemens Healthineers and Kodak. CXR
= chest x-ray radiography, COVID-19 = coronavirus disease 2019
Table 2. Test Performance of CV19-Net for Different Vendors
Vendors
V3

V4

Overall

900

534

5869

405

360

2193

0.93 (0.91-0.94)

0.91 (0.880.94)

0.92 (0.910.93)

89% (84%93%)
78% (73%82%)

88% (87%89%)
79% (77%80%)

77% (70%83%)
88% (85%92%)

78% (77%79%)
89% (88%90%)

In

Pr

Parameter
V1
V2
A. Performance
No.
2799
1271
images
No.
1160
713
patients
0.92 (0.910.90 (0.88AUC
0.93)
0.92)
*
B. High sensitivity operating point
90% (88%86% (83%Sensitivity
91%)
88%)
78% (76%77% (73%Specificity
81%)
80%)
†
C. High specificity operating point
80% (78%75% (72%Sensitivity
82%)
78%)
90% (88%88% (85%Specificity
92%)
91%)

87% (84%-90%)
82% (78%-85%)

77% (73%-81%)
90% (87%-93%)

Note.—Values in parenthesis are 95% confidence intervals. AUC = area under the receiver operating
characteristic curve.
*
†

Threshold of T1 = 0.4.
Threshold of T2 = 0.6.

Table 3. Test Performance of CV19-Net for Different Age Groups
Age group
Parameter

18-30

30-45

45-60

60-75

≥75

No. images

211

532

1519

2259

1348

No. patients

93

218

509

800

573

AUC

0.96 (0.940.98)

0.94 (0.930.96)

0.93 (0.910.94)

0.92 (0.910.93)

0.89 (0.880.91)

B. High sensitivity operating point*
90% (84%96%)

91% (87%94%)

92% (90%94%)

88% (86%90%)

82% (79%85%)

Specificity

89% (84%95%)

83% (79%88%)

73% (70%77%)

79% (76%81%)

80% (77%83%)

es

Sensitivity

s

A. Performance

C. High specificity operating point†
78% (70%87%)

85% (80%89%)

84% (81%86%)

78% (75%80%)

69% (66%72%)

Specificity

94% (89%98%)

91% (88%94%)

85% (83%88%)

89% (88%91%)

90% (88%92%)

Pr

Sensitivity

Note.—Values in parenthesis are 95% confidence intervals. AUC = area under the receiver operating
characteristic curve.
*

Threshold of T1 = 0.4.
Threshold of T2 = 0.6.

In

†

Table 4. Test Performance of CV19-Net for Men and Women
Sex
Parameter

Men

Women

No. images

3521

2348

No. patients

1131

1062

0.92 (0.91-0.93)

0.91 (0.90-0.92)

AUC

B. High sensitivity operating point*
88% (87%-89%)

Specificity

79% (77%-81%)

89% (87%-90%)

78% (75%-80%)

es

Sensitivity

s

A. Performance

C. High specificity operating point†
Sensitivity

78% (76%-80%)

79% (76%-81%)

Specificity

90% (88%-91%)

89% (87%-91%)

*

Threshold of T1 = 0.4.
Threshold of T2 = 0.6.
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†
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Note.—Values in parenthesis are 95% confidence intervals. AUC = area under the receiver operating
characteristic curve.

Appendix E1: Bias Mitigation
In image classification tasks, machine learning methods use image intensity values to extract
digital image features and then use these image features to compute, for example, the COVID-19
probability score of an input CXR. Therefore, the actual digital values in each CXR image
determine the final machine learning classification decision of the input CXR. However,

s

different vendors of CXR imaging systems use different proprietary postprocessing algorithms to
process digital CXRs (ie each vendor will adjust their final digital values differently for desired

es

image contrast for interpretation). Further, many hospitals and clinics often use multiple CXR
imaging systems from different vendors. Additionally, different clinics and different

technologists may choose different imaging parameters such as x-ray tube potential (kVp values)
and x-ray exposure levels (mAs values) to acquire the CXR. As a result, similar pneumonia
findings may have very different digital image representations in retrospectively collected digital

Pr

CXRs. Without taking these variables into account, machine learning algorithms may produce
biased results.

Appendix E2: Image Preprocessing

In

The DICOM files were resized to 1024 × 1024 and saved as 8-bit PNG grayscale images. The
image intensity value was adjusted based on the window level and window width attributes in
the DICOM file. Contrast inversion is applied for images with DICOM attribute
MONOCHROME1. See Figure E1 for the flow chart of the image preprocessing step.
Before being fed into the network, PNG images were further downscaled to 224 × 224,

converted to red (R)- green (G) -blue (B) images and normalized based on the mean and standard
deviation of images in the ImageNet dataset:

𝑅 = (𝑅 − 0.485)/0.229
𝐺 = (𝐺 − 0.456)/0.224
𝐵 = (𝐵 − 0.406)/0.225

Appendix E3: Network Architecture and Training

s

The DenseNet-1211 architecture with 50 convolutional neural network (CNN) layers was used as
the image feature extraction module of CV19-Net. Followed by the last convolutional layer of

es

DenseNet-121 (layer 120) is a fully connected (FC) classifier with a Softmax activation function
to combine the extracted feature vector for the final predicted probability score.

A three-stage transfer learning process was used in model training (see Figure E2):

1. Stage one: The image feature extraction module was trained on ImageNet images with 14

Pr

million images to differentiate between 1,000 image classes.

2. Stage two: The network was initialized with weights trained in stage one and was further
trained using the NIH data set with 112,120 chest x-ray images from 30,805 unique patients
to classify chest x-ray images into 14 different disease classes. A similar design was used in
CheXNet.2 This step allows the network to learn CXR-specific image features.

In

3. Stage three: The network was initialized using weights obtained from stage two and trained
using our training dataset consists of 5,236 CXRs (2,582 CXRs from the COVID-19 cohort
and 2,654 CXRs from the non-COVID-19 pneumonia cohort) to train the network to perform

the final binary classification: COVID-19 and non-COVID-19 pneumonia classification.

CV19-Net (Figure E3) was developed using the PyTorch framework. The network was trained to
minimize the binary cross entropy loss. Adam optimizer was used with an initial learning rate

=6.0 × 10

for all convolutional layers and 1.0 × 10

for the FC classifier. The minibatch size

was empirically selected to be 50. Data augmentation techniques including rotation (30-degree
range) and horizontal flipping were used. To prevent model overfitting, an early stopping
strategy was adopted by monitoring the training loss on the validation set. The validation set was
randomly sampled from the total training dataset (25% of the training samples). The model with
the lowest validation loss was taken as the final model for prediction. To reduce fluctuations of

s

prediction results, the well-known ensemble averaging technique common in machine learning
was introduced in this work. The prediction scores of input images from N=20 individually

es

trained networks with identical training parameters, but different random seeds in model

initialization and different randomly sampled validation sets. A quadratic mean of the prediction
probability scores was taken to generate the final predication probability score:
𝑆=

∑

𝑆 (𝑖)

/

(N=20).

Pr

This final probability score was compared with the selected threshold values in decision making
to perform binary classification.

Appendix E4: Class Activation Maps

To help visualize which part of the input images contributed most to CV19-Net's decision used

In

to produce the final probability score, a heat map employing the gradient-weighted Class
Activation Mapping (Grad-CAM)3 was used to highlight those key image pixels in the CXR
image primarily responsible for COVID-19 pneumonia. The paired heatmap of COVID-19
image features and the original CXR images are presented in Figure E4 to help aid human eyes
to identify the key morphological and contextual features in CXR images.

Appendix E5: Additional Statistical Analyses
(a) Test performance difference on men and women
The following statistical hypothesis testing was performed:

H0 : AUC(male) = AUC(female) vs.

s

H1 : AUC(male) ≠ AUC(female)

es

P-value method was used in hypothesis testing with a rejection p-value of .05. Result shows
P=.17, therefore no statistically significant difference between two groups.
(b) Test performance difference on patients of different age groups

Pr

The following statistical hypothesis testing was performed:

H0 : AUC(Group-i) = AUC(Group-j) vs.
H1 : AUC(Group-i) ≠ AUC(Group-j)

In

Results are shown in Table E1.
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Supplementary Figures

In

Figure E1: Flow chart showing the image preprocessing method.

Figure E2: Individual network architecture and training process in CV19-Net.

s
es

Figure E3: CV19-Net: An ensemble of individually trained deep neural network models to

In

Pr

perform ensemble prediction of an input image.

Figure E4: Class activation map examples.
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Figure E5: AUC vs. training sample size and the increment of AUC vs increment of training
sample size. After the training sample size goes beyond 3000 (1500 positive and 1500 negative
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cases), the performance gain with the increase of training sample is diminished.

Supplementary Tables

Table E1. Paired AUC Difference between Different Age Groups
Table E1. Age group AUC difference, P-value
18-30
30-45

75-90

.31

.02

.002

<.001

.01

<.001

.25

.002
.02

es

In

Pr

75-90

60-75

.13

45-60
60-75

45-60

s

18-30

30-45

Table E2. Related Works
Reference

Number of positive
CXRs in
training/validation

Number of positive
CXRs in testing

Data type

Pereira et al.4

63

27

Cohen5

Rahimzadeh et al.6

149

31

Cohen

267

Cohen

Ozturk et al.8

127

Cohen

Kishore et al.9

150

Narin et al.10

269

Gil et al.11

288

Khan et al.13
Elasnaoui et al.14
Afshar et al.15

Cohen
Cohen

100

Cohen

284

Cohen

231

Cohen

Not clear

Cohen

Pr

Karim et al.16

Cohen

es

Horry et al.12

s

Zokaeinikoo et al.7

149

31

Cohen

144

36

Cohen

Farooq et al.21

Wang

Oh et al.17

Wang et al.18

358

Wang

Luz et al.19

152

31

Wang

Ucar et al.20

66

10

Wang

68
232

51

Wang

Majeed et al.23

111

73

Cohen, Kaggle

Zhang et al.24

258

60

Cohen, Kaggle

Kumar et al.25

42

20

SIRM

Tahir et al.26

338

85

Cohen, SIRM,
Radiopaedia,

Yeh et al.27

415

95

Local hospital

Schwab et al.28

391

167

Local hospital
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Shibly et al.22

Murphy et al.29

512

468

Local hospital
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SIRM: https://www.sirm.org/category/senza-categoria/covid-19
Cohen: https://github.com/ieee8023/covid-chestxray-dataset
Kaggle: https://www.kaggle.com/andrewmvd/covid19-X-rays
Wang: https://github.com/lindawangg/COVID-Net
Radiopaedia: https://radiopaedia.org/playlists/25975?
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